Indian Scientists have made a major breakthrough in the field of Cancer diagnosis. Mumbai Based Epigeneres Biotech Private Limited and its sister concern Singapore based Tzar Labs have devised a non invasive test which will be able to accurately prognose presence of Cancer in the body even before an year the tumour cells are formed and related symptoms are visible. This technique which is known as HrC test will help in early diagnosis and treatment of Cancer. The HrC test will also save the Cancer patients from the burden of huge financial implications involved in treatment of tumour cells at a later stage.<br />”&nbsp;<br />”Speaking exclusively to AIR News, Promoter Director of Epigeneres Biotech Pvt limited, Mr. Ashish Tripathi said the special point of the diagnosis is that it can be conducted by a simple blood test.<br />”<b>&nbsp;</b><br />”<span style="color: #222222;">Mr. Tripathi also informed that HrC test is a novel, non-invasive, blood test that can detect all types of cancers, including solid tumours, haematological malignancies, and sarcomas. He said, this study was published in the April issue of SCRR (Stem Cell Reviews and Reports) a quarterly medical journal published by Berlin-based, Springer Science and Business Media.&nbsp;</span><br />